Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Cannabis Transdermal Patches among products to launch in July under Atlas Thrive™ – Powered by MÜV™ in partnership with Verano (VRNO)
  • The patented MÜV products, including fast-acting patches, gels, and tinctures, will be available for purchase online in July for medical cannabis patients
  • Atlas will also distribute its “Powered by MÜV” branded gels, patches, and tinctures through brick-and-mortar networks in Ontario, Alberta, British Columbia, Saskatchewan, New Brunswick, Yukon and the Northwest Territories
  • The products will be available through Ontario Cannabis Stores on July 13 and through Alberta Gaming, Liquor and Cannabis in August
  • Verano Holdings Corp. (VRNO) is down 0.91 per cent, trading at C$19.69 at 2:06 pm ET

Atlas Biotechnologies has launched Atlas Thrive – Powered by MÜV™ branded products in collaboration with Verano Holdings Corp. (VRNO).

Powered by MÜV patches, gels and tinctures will be available exclusively through Shoppers Drug Mart’s online storefront at launch. Atlas and Verano will bring Powered by MÜV products to brick-and-mortar stores across Canada with a launch date of transdermal patches at OCS on July 13 and at AGLC in August.

“As a leader in the Canadian cannabis space, we are keen to provide effective, smokeless, and reliable health and wellness solutions to millions of Canadians,” said Sheldon Croome, Atlas Founder and CEO.

“We’re pleased by the scope of this opportunity and the expanded footprint it provides Verano in accessing the Canadian cannabis market through the largest pharmacy chain in the country,” said George Archos, Verano Co-Founder and CEO.

“The prospect of introducing our award-winning MÜV products to a new market and new patients and consumers is an exciting opportunity for the company,” added Archos.

The patented MÜV products, including fast-acting patches, gels, and tinctures, will be available for purchase online in July for medical cannabis patients in Canada under the Atlas Thrive™ brand through Shoppers Drug Mart.

Shoppers Drug Mart is the largest pharmacy chain in Canada, which is accessible to over 400 thousand patients with medical cannabis prescriptions.

The Atlas Thrive MÜV THC Tincture and 1:1 Transdermal Patch will also be launching through OCS and available to the Ontario market online, and across over 800 retailers, on July 13, with Alberta following suit in August across over 600 more retailers.

Atlas Biotechnologies Inc. is based in Edmonton, Canada and its wholly-owned subsidiaries, Atlas Growers Ltd. is federally licensed in Canada for the cultivation and production of cannabis products, with a focus on health and wellness.

Atlas currently produces dried flower, extract, topical and edible formulations with medical distribution across Canada and adult-use distribution in 7 provinces and territories, accessing over 70 per cent of the Canadian population.

Verano Holdings Inc. is a leading multi-state cannabis operator in the U.S., devoted to the ongoing improvement of communal wellness by providing responsible access to regulated cannabis products.

Verano Holdings Corp. (VRNO) is down 0.91 per cent, trading at C$19.69 at 2:06 pm ET.

More From The Market Herald

" Potent Ventures (CSE:POT) is now “The Gummy Project Inc.”

Potent Ventures (POT) has received shareholder and CSE approval for its change of business.
Canopy Growth - CEO, David Klein

" Canopy Growth (TSX:WEED) reports Q4 and FY2022 financial results

Canopy Growth Corporation (WEED) has released its financial results for the fourth quarter and fiscal year ended March 31, 2022.